Bone Biologics BBLG
NASDAQ BBLG
$0.42 -0.01 (-2.33%)
As of: Oct 21, 2026 · 3:59 PM EDT

Bone Biologics (BBLG) Current Debt (2021)

Updated

Bone Biologics (BBLG) posted Current Debt of -$10,609 for FY2021, compared with $10,609 in FY2020.

Analysis

Bone Biologics (BBLG) Current Debt (2021) Analysis & Trends

  • Business Quant data shows BBLG's Current Debt at $10,609 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn -
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 64.00 Mn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 1.93 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn -
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 812.00 Mn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn -
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 1.68 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn -291.00 Mn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn -
10 Bone Biologics 738,825.63 -21.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -10,609.00
API Access

Bone Biologics Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=BBLG&period=max&api_key=YOUR_API_KEY